Emerging Technology Platforms for Drug Discovery and Development

Share this:
Published: 14 Jul 2017

The latest edition of the Drug Discovery TechVision Opportunity Engine (TOE) profiles emerging technology platforms for drug discovery and development. These platforms are diverse and span the spectrum of the life sciences industry, from tissue engineering to companion diagnostics, biomarkers, and cell therapy. This TOE issue strikes a balance between innovations at the academia research setting and technologies that have received regulatory approval and have been commercialized. The Health and Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare. Keywords: Companion diagnostics, tissue engineering, biomarkers, artificial intelligence, cell therapy


Features of this research


Help Desk

Full list of offices

For more information and general enquiries, contact Frost & Sullivan near you.

North America
tel: +1.877.463.7678

Select a location near you..